How do APR and PQR differ in terms of the number of batches to be assessed in the review period?

12.09.2022

Question of the Week

While all batches have to be checked for the specified issues in the EU GMP Guide for the PQR, 21 CFR 211.180(e) requires a representative number of batches for the APR. There is however also a requirement to ensure that changes or irregularities are taken into account.

[GMP Compliance Adviser, Chapter 1.J]

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

19.01.2026

Question of the Week

What is a gas?

You can view the answer here:

EMA: Pilot Programme for Breakthrough Devices

The EMA plans to launch a pilot programme in Q2 2026 to implement the guidance for breakthrough devices issued in December 2025.

EDQM: New Ph. Eur. Chapter on Data Quality with a Focus on Digital Data

The European Pharmacopoeia (Ph. Eur.) has introduced a new general chapter that provides a framework for managing the quality of data, including digital data, throughout its life cycle.